Equities analysts expect that LifePoint Health Inc (NASDAQ:LPNT) will report earnings of $0.82 per share for the current quarter, Zacks Investment Research reports. Nine analysts have made estimates for LifePoint Health’s earnings, with the lowest EPS estimate coming in at $0.74 and the highest estimate coming in at $0.91. LifePoint Health reported earnings per share of $1.09 during the same quarter last year, which would indicate a negative year-over-year growth rate of 24.8%. The company is expected to announce its next earnings report on Friday, February 16th.
On average, analysts expect that LifePoint Health will report full year earnings of $3.67 per share for the current financial year, with EPS estimates ranging from $3.56 to $4.01. For the next fiscal year, analysts anticipate that the company will report earnings of $4.04 per share, with EPS estimates ranging from $3.53 to $4.60. Zacks Investment Research’s earnings per share calculations are an average based on a survey of analysts that cover LifePoint Health.
LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.15). LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.60 billion. During the same quarter in the prior year, the company earned $0.94 earnings per share. The company’s quarterly revenue was down .7% on a year-over-year basis.
Shares of LifePoint Health (LPNT) traded up $1.80 on Friday, hitting $49.25. The stock had a trading volume of 958,853 shares, compared to its average volume of 462,017. LifePoint Health has a 12-month low of $42.50 and a 12-month high of $70.95. The company has a market capitalization of $1,940.00, a PE ratio of 12.56, a PEG ratio of 1.28 and a beta of 0.67. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.65 and a current ratio of 1.85.
LifePoint Health announced that its Board of Directors has initiated a stock buyback program on Friday, October 27th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase programs are usually an indication that the company’s board of directors believes its shares are undervalued.
In other LifePoint Health news, Director Marguerite Kondracke sold 3,416 shares of the company’s stock in a transaction that occurred on Tuesday, November 21st. The stock was sold at an average price of $43.80, for a total value of $149,620.80. Following the completion of the sale, the director now owns 17,479 shares of the company’s stock, valued at $765,580.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 8.76% of the stock is owned by corporate insiders.
A number of institutional investors and hedge funds have recently modified their holdings of the business. Teacher Retirement System of Texas boosted its stake in LifePoint Health by 0.3% in the second quarter. Teacher Retirement System of Texas now owns 3,211 shares of the company’s stock worth $216,000 after buying an additional 9 shares in the last quarter. US Bancorp DE boosted its stake in LifePoint Health by 0.8% in the second quarter. US Bancorp DE now owns 1,947 shares of the company’s stock worth $130,000 after buying an additional 16 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in LifePoint Health by 1.0% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,891 shares of the company’s stock worth $396,000 after buying an additional 56 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock worth $113,000 after buying an additional 164 shares in the last quarter. Finally, ETRADE Capital Management LLC boosted its stake in LifePoint Health by 3.9% in the second quarter. ETRADE Capital Management LLC now owns 6,896 shares of the company’s stock worth $463,000 after buying an additional 262 shares in the last quarter. 99.18% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: This article was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://stocknewstimes.com/2017/12/17/0-82-earnings-per-share-expected-for-lifepoint-health-inc-lpnt-this-quarter.html.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.